WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities
Now approved for both acute and chronic HCV in adults and children aged 3 and above
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
